| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,044 |
3,207 |
$805K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,701 |
16,459 |
$784K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,286 |
1,814 |
$605K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,390 |
1,863 |
$587K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,556 |
2,204 |
$447K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,266 |
969 |
$447K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,380 |
8,462 |
$423K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,969 |
1,474 |
$409K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
463 |
421 |
$379K |
| 80053 |
Comprehensive metabolic panel |
12,819 |
10,527 |
$359K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,003 |
1,315 |
$332K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,702 |
10,982 |
$291K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,194 |
1,714 |
$290K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,086 |
1,513 |
$244K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,571 |
1,475 |
$208K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,156 |
827 |
$196K |
| G0378 |
Hospital observation service, per hour |
66 |
52 |
$160K |
| 70450 |
Computed tomography, head or brain; without contrast material |
380 |
339 |
$155K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,632 |
2,134 |
$118K |
| 36415 |
Collection of venous blood by venipuncture |
12,814 |
10,639 |
$118K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,910 |
4,643 |
$115K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
156 |
75 |
$76K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,208 |
1,677 |
$76K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
922 |
353 |
$74K |
| 80061 |
Lipid panel |
2,803 |
2,711 |
$70K |
| 84484 |
|
2,019 |
1,400 |
$69K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
328 |
170 |
$67K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
609 |
563 |
$66K |
| 71046 |
Radiologic examination, chest; 2 views |
956 |
895 |
$62K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,254 |
3,107 |
$62K |
| 71045 |
Radiologic examination, chest; single view |
1,638 |
1,405 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
871 |
751 |
$52K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
423 |
254 |
$50K |
| 82607 |
|
1,253 |
1,211 |
$46K |
| 83605 |
|
1,527 |
1,094 |
$42K |
| 81025 |
|
1,325 |
1,234 |
$34K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,603 |
1,446 |
$34K |
| 80050 |
General health panel |
284 |
282 |
$33K |
| 84439 |
|
1,268 |
1,223 |
$32K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
225 |
217 |
$32K |
| 86140 |
|
1,939 |
1,649 |
$32K |
| 81001 |
|
2,706 |
2,366 |
$26K |
| J2704 |
Injection, propofol, 10 mg |
1,254 |
982 |
$25K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
15 |
14 |
$23K |
| 85651 |
|
1,854 |
1,625 |
$22K |
| 83880 |
|
787 |
622 |
$21K |
| 83690 |
|
957 |
812 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
791 |
768 |
$19K |
| 84145 |
|
770 |
643 |
$19K |
| 99307 |
|
2,929 |
823 |
$17K |
| 81003 |
|
1,674 |
1,506 |
$17K |
| 83735 |
|
993 |
845 |
$17K |
| 97161 |
|
193 |
181 |
$15K |
| 82746 |
|
496 |
480 |
$15K |
| 87186 |
|
704 |
576 |
$15K |
| 97113 |
|
126 |
37 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
751 |
704 |
$13K |
| 80305 |
|
798 |
684 |
$13K |
| 83540 |
|
662 |
622 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
168 |
81 |
$12K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
223 |
210 |
$11K |
| 81002 |
|
1,715 |
1,582 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
55 |
55 |
$11K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
12 |
$11K |
| 85610 |
|
1,072 |
772 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
242 |
213 |
$8K |
| 82728 |
|
224 |
212 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
861 |
829 |
$8K |
| 73030 |
|
78 |
70 |
$7K |
| 83550 |
|
356 |
332 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
254 |
143 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
797 |
566 |
$6K |
| 87088 |
|
371 |
333 |
$6K |
| 96376 |
|
55 |
39 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
253 |
223 |
$6K |
| 90686 |
|
249 |
244 |
$5K |
| 87400 |
|
75 |
69 |
$5K |
| 84153 |
|
129 |
125 |
$4K |
| 73630 |
|
38 |
38 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
169 |
153 |
$3K |
| 82150 |
|
170 |
150 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,476 |
1,225 |
$3K |
| 80306 |
|
51 |
45 |
$3K |
| 82962 |
|
280 |
157 |
$3K |
| 82553 |
|
145 |
108 |
$3K |
| 99215 |
Prolong outpt/office vis |
179 |
85 |
$3K |
| 82550 |
|
345 |
285 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
38 |
38 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
866 |
495 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,535 |
1,316 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
25 |
25 |
$3K |
| 90688 |
|
96 |
94 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
162 |
162 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
222 |
169 |
$2K |
| 72100 |
|
13 |
13 |
$2K |
| 73560 |
|
36 |
28 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
353 |
243 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
966 |
738 |
$2K |
| 85379 |
|
26 |
24 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
16 |
12 |
$2K |
| 87077 |
|
86 |
76 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
117 |
104 |
$2K |
| 99335 |
|
44 |
43 |
$2K |
| 0124A |
|
36 |
36 |
$1K |
| 87040 |
|
30 |
12 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
19 |
12 |
$1K |
| 84550 |
|
60 |
59 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
219 |
211 |
$1K |
| 82570 |
|
64 |
57 |
$1K |
| 84481 |
|
45 |
45 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
510 |
399 |
$1K |
| 87081 |
|
29 |
26 |
$952.84 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
139 |
100 |
$938.77 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
221 |
137 |
$842.56 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
55 |
55 |
$780.11 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
320 |
239 |
$756.50 |
| 86803 |
|
12 |
12 |
$640.79 |
| 83874 |
|
22 |
14 |
$557.92 |
| 82043 |
|
50 |
43 |
$525.84 |
| 85730 |
|
14 |
12 |
$518.77 |
| 90662 |
|
91 |
87 |
$419.62 |
| 84702 |
|
14 |
13 |
$413.54 |
| 99334 |
|
13 |
12 |
$159.04 |
| A9270 |
Non-covered item or service |
4,687 |
1,956 |
$53.18 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
41 |
37 |
$26.24 |
| G0008 |
Administration of influenza virus vaccine |
227 |
219 |
$0.00 |
| 91307 |
|
17 |
15 |
$0.00 |
| 80320 |
|
14 |
12 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
228 |
71 |
$0.00 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
15 |
13 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
28 |
24 |
$0.00 |
| 91312 |
|
34 |
34 |
$0.00 |
| 91300 |
|
16 |
15 |
$0.00 |